Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 37, Supplement C, June 1996   [Index by Author] 


Down Other Departments
Down Articles


[Search ALL Issues]


Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Other Departments Back

Roger G. Finch, Erwin M. Brown, and Robert C. Spencer
Preface
J. Antimicrob. Chemother. 1996 37: iii; doi:10.1093/jac/37.suppl_C.iii [PDF] [Request Permissions]  

Articles Back

H. Lode, K. Borner, P. Koeppe, and T. Schaberg
Azithromycin—review of key chemical, pharmacokinetic and microbiological features
J. Antimicrob. Chemother. 1996 37: 1-8; doi:10.1093/jac/37.suppl_C.1 [Abstract] [PDF] [Request Permissions]  

A. E. Girard, C. R. Cimochowski, and J. A. Faiella
Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection
J. Antimicrob. Chemother. 1996 37: 9-19; doi:10.1093/jac/37.suppl_C.9 [Abstract] [PDF] [Request Permissions]  

D. Girard, P. A. Regan, W. B. Milisen, J. A. Retsema, and A. C. Swindell
Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues
J. Antimicrob. Chemother. 1996 37: 21-35; doi:10.1093/jac/37.suppl_C.21 [Abstract] [PDF] [Request Permissions]  

G. Foulds, D. R. Luke, R. Teng, S. A. Willavize, H. Friedman, and W. J. Curatolo
The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension
J. Antimicrob. Chemother. 1996 37: 37-44; doi:10.1093/jac/37.suppl_C.37 [Abstract] [PDF] [Request Permissions]  

B. P. Vaudaux, J. Cherpillod, and P. Dayer
Concentrations of azithromycin in tonsillar and/or adenoid tissue from paediatric patients
J. Antimicrob. Chemother. 1996 37: 45-51; doi:10.1093/jac/37.suppl_C.45 [Abstract] [PDF] [Request Permissions]  

J. Pukander and M. Rautianen
Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children
J. Antimicrob. Chemother. 1996 37: 53-61; doi:10.1093/jac/37.suppl_C.53 [Abstract] [PDF] [Request Permissions]  

A. F. Rodriguez
An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media
J. Antimicrob. Chemother. 1996 37: 63-69; doi:10.1093/jac/37.suppl_C.63 [Abstract] [PDF] [Request Permissions]  

B. O'Doherty
An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections
J. Antimicrob. Chemother. 1996 37: 71-81; doi:10.1093/jac/37.suppl_C.71 [Abstract] [PDF] [Request Permissions]  

O. Müller
An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections
J. Antimicrob. Chemother. 1996 37: 83-92; doi:10.1093/jac/37.suppl_C.83 [Abstract] [PDF] [Request Permissions]  

P. Gris
Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study
J. Antimicrob. Chemother. 1996 37: 93-101; doi:10.1093/jac/37.suppl_C.93 [Abstract] [PDF] [Request Permissions]  

J. Zachariah
A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections
J. Antimicrob. Chemother. 1996 37: 103-113; doi:10.1093/jac/37.suppl_C.103 [Abstract] [PDF] [Request Permissions]  

K. Laurent
Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections
J. Antimicrob. Chemother. 1996 37: 115-124; doi:10.1093/jac/37.suppl_C.115 [Abstract] [PDF] [Request Permissions]  

L. Montero
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections
J. Antimicrob. Chemother. 1996 37: 125-131; doi:10.1093/jac/37.suppl_C.125 [Abstract] [PDF] [Request Permissions]  

M. Nahata
Drug interactions with azithromycin and the macrolides: an overview
J. Antimicrob. Chemother. 1996 37: 133-142; doi:10.1093/jac/37.suppl_C.133 [Abstract] [PDF] [Request Permissions]  

G. Treadway and D. Pontani
Paediatric safety of azithromycin: worldwide experience
J. Antimicrob. Chemother. 1996 37: 143-149; doi:10.1093/jac/37.suppl_C.143 [Abstract] [PDF] [Request Permissions]  

C. Carbon, J. M. Hotton, L. F. Pépin, C. Wohlhuter, E. Souêtre, M. Hardens, H. Lozet, and M. Riviera
Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin
J. Antimicrob. Chemother. 1996 37: 151-161; doi:10.1093/jac/37.suppl_C.151 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.